YolTech Therapeutics to Initiate a Clinical Trial for YOLT-204, a First-in-Class Bone Marrow-Targeted In Vivo Gene Editing Therapy for β-Thalassemia
SHANGHAI, Jan. 21, 2025 /PRNewswire/ -- YolTech Therapeutics, a clinical-stage gene editing company dedicated to delivering lifelong cures, announced the initiation of a clinical trial for YOLT-204, an investigational therapy for the treatment of transfusion-dependent beta-thalassemia (TDT). TDT is a severe genetic blood disorder where mutations in the beta-globin gene leads to reduced or absence of hemoglobin, a condition where...
AXA and Prosper Health introduce pioneering dedicated cancer case management service in Greater Bay Area[1]
Partners with Prosper Healthintroducing "Greater Bay Area Cancer Medical Concierge Service Network" HONG KONG, Jan. 21, 2025 /PRNewswire/ -- AXA Hong Kong and Macau ("AXA") announces a partnership with Prosper Health, a member-centric health insurance service provider under New Frontier Group - one of China's leading integrated private healthcare service institutions, to launch premium cross-border medical support services for eligible AXA customers, to further...
MedAdvisor Solutions’ helps pharmacists in Australia deliver more than 115,000 clinical services to patients through Expanded Scope of Practice Pilots in 2024
New case study showcases improved operational efficiency and patient care with enhanced workflow and clinical services for pharmacists MELBOURNE, Australia, Jan. 21, 2025 /PRNewswire/ -- MedAdvisor Solutions, a global leader in patient engagement and pharmacy technology, published its newest case study revealing the success of Australia's Expanded Scope of Practice initiative...
MicroAire Completes Acquisition of NEOSYAD
CHARLOTTESVILLE, Va., Jan. 21, 2025 /PRNewswire/ -- MicroAire Surgical Instruments, the global leader in power-assisted liposuction, is pleased to announce the acquisition of NEOSYAD, an innovative medical device company that developed a breakthrough technology for adipose tissue engineering. This strategic move reinforces MicroAire's commitment to advancing medical innovation and strengthening its...
CARsgen’s Allogeneic CD38 CAR-T Therapy Administers First Dose in an Investigator-Initiated Trial
SHANGHAI, Jan. 20, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that KJ-C2320, an allogeneic CAR T-cell therapy targeting CD38, has administered the first dose to a patient in an investigator-initiated trial...
SIRPAD – WORLD’S LARGEST RCT INVESTIGATING MAGICTOUCH PTA SIROLIMUS COATED BALLOON COMPLETES PATIENT ENROLMENT
TAMPA, Fla., Jan. 20, 2025 /PRNewswire/ -- Concept Medical Inc. (CMI), a global leader in innovative drug-delivery technology across vascular interventions, proudly announces the successful completion of patient enrolment in the SirPAD Trial, with over 1,250 patients now enrolled. Concept Medical proudly announces that over 1,250 patients have successfully enrolled in...
HKUST Develops World’s Smallest Multifunctional Biomedical Robot for Interventional Diagnosis and Treatment
HONG KONG, Jan. 20, 2025 /PRNewswire/ -- Researchers from the School of Engineering of the Hong Kong University of Science and Technology (HKUST) have successfully developed the world's smallest multifunctional biomedical robot, which is 60% smaller than current models. Capable of imaging, high-precision motion, and multifunctional operations like sampling, drug delivery, and laser ablation, the robot offers competitive imaging...
2025 Yili Elite Summit Celebrates Employee Contributions with a Focus on Respect and Well-being
HOHHOT, China, Jan. 18, 2025 /PRNewswire/ -- Recently, the Yili Elite Summit took place in Hohhot, Inner Mongolia. A total of 400 participants, including 200 employees and their families, gathered at Yili's headquarters to celebrate this annual event. During the event, Mr. Pan Gang, Chairman and President of Yili Group, highlighted the crucial role employees play in...
MediBeacon® Transdermal GFR System Receives FDA Approval to Assess Kidney Function
Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal function. The transdermal GFR (tGFR) methodology has been designed to be effective across the adult population without input of age, weight, sex, gender, race, or ethnicity. More than...
Boosting Yeast Protein Production to Meet the Growing Global Demand for Alternative Proteins
YICHANG, China, Jan. 17, 2025 /PRNewswire/ -- Angel Yeast (SH600298), a global leader in yeast manufacturing, has officially completed the topping out of the main plant for the industrial yeast protein production project at Baiyang Yichang, which will boost an annual output of 11,000 tons, a milestone of Angel Yeast's sustainable protein development...
